Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Obesity
|
1111 | 0.627 | 0.640 | 1 | 65570758 | missense variant | A/G | snv | 0.30 | 0.25 | 0.100 | 1.000 | 10 | 2001 | 2018 | ||||
Breast Carcinoma
|
2793 | 0.627 | 0.640 | 1 | 65570758 | missense variant | A/G | snv | 0.30 | 0.25 | 0.040 | 1.000 | 4 | 2011 | 2017 | ||||
Diabetes Mellitus, Non-Insulin-Dependent
|
2672 | 0.627 | 0.640 | 1 | 65570758 | missense variant | A/G | snv | 0.30 | 0.25 | 0.040 | 0.750 | 4 | 2005 | 2019 | ||||
Malignant neoplasm of breast
|
3417 | 0.627 | 0.640 | 1 | 65570758 | missense variant | A/G | snv | 0.30 | 0.25 | 0.040 | 1.000 | 4 | 2011 | 2017 | ||||
Arteriosclerosis
|
267 | 0.627 | 0.640 | 1 | 65570758 | missense variant | A/G | snv | 0.30 | 0.25 | 0.020 | 1.000 | 2 | 2010 | 2015 | ||||
Atherosclerosis
|
281 | 0.627 | 0.640 | 1 | 65570758 | missense variant | A/G | snv | 0.30 | 0.25 | 0.020 | 1.000 | 2 | 2010 | 2015 | ||||
Hypertensive disease
|
1085 | 0.627 | 0.640 | 1 | 65570758 | missense variant | A/G | snv | 0.30 | 0.25 | 0.020 | 1.000 | 2 | 2012 | 2019 | ||||
Impaired glucose tolerance
|
81 | 0.627 | 0.640 | 1 | 65570758 | missense variant | A/G | snv | 0.30 | 0.25 | 0.020 | 1.000 | 2 | 2001 | 2005 | ||||
Malignant neoplasm of prostate
|
1082 | 0.627 | 0.640 | 1 | 65570758 | missense variant | A/G | snv | 0.30 | 0.25 | 0.020 | 0.500 | 2 | 2003 | 2014 | ||||
Non-alcoholic Fatty Liver Disease
|
222 | 0.627 | 0.640 | 1 | 65570758 | missense variant | A/G | snv | 0.30 | 0.25 | 0.020 | 1.000 | 2 | 2013 | 2018 | ||||
Prostate carcinoma
|
1168 | 0.627 | 0.640 | 1 | 65570758 | missense variant | A/G | snv | 0.30 | 0.25 | 0.020 | 0.500 | 2 | 2003 | 2014 | ||||
Asthma
|
1536 | 0.627 | 0.640 | 1 | 65570758 | missense variant | A/G | snv | 0.30 | 0.25 | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||
Carcinoma of lung
|
1204 | 0.627 | 0.640 | 1 | 65570758 | missense variant | A/G | snv | 0.30 | 0.25 | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||
Cardiovascular Diseases
|
711 | 0.627 | 0.640 | 1 | 65570758 | missense variant | A/G | snv | 0.30 | 0.25 | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||
Childhood Acute Lymphoblastic Leukemia
|
261 | 0.627 | 0.640 | 1 | 65570758 | missense variant | A/G | snv | 0.30 | 0.25 | 0.010 | 1 | 2011 | 2011 | |||||
Conventional (Clear Cell) Renal Cell Carcinoma
|
222 | 0.627 | 0.640 | 1 | 65570758 | missense variant | A/G | snv | 0.30 | 0.25 | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||
Coronary Artery Disease
|
1577 | 0.627 | 0.640 | 1 | 65570758 | missense variant | A/G | snv | 0.30 | 0.25 | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||
Dystrophia myotonica 2
|
21 | 0.627 | 0.640 | 1 | 65570758 | missense variant | A/G | snv | 0.30 | 0.25 | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||
Essential Hypertension
|
293 | 0.627 | 0.640 | 1 | 65570758 | missense variant | A/G | snv | 0.30 | 0.25 | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||
HELLP Syndrome
|
10 | 0.627 | 0.640 | 1 | 65570758 | missense variant | A/G | snv | 0.30 | 0.25 | 0.010 | 1.000 | 1 | 2010 | 2010 | ||||
Ischemic stroke
|
704 | 0.627 | 0.640 | 1 | 65570758 | missense variant | A/G | snv | 0.30 | 0.25 | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||
Lip and Oral Cavity Carcinoma
|
172 | 0.627 | 0.640 | 1 | 65570758 | missense variant | A/G | snv | 0.30 | 0.25 | 0.010 | 1 | 2019 | 2019 | |||||
Liver carcinoma
|
942 | 0.627 | 0.640 | 1 | 65570758 | missense variant | A/G | snv | 0.30 | 0.25 | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||
Liver diseases
|
100 | 0.627 | 0.640 | 1 | 65570758 | missense variant | A/G | snv | 0.30 | 0.25 | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||
Lupus Erythematosus, Systemic
|
1172 | 0.627 | 0.640 | 1 | 65570758 | missense variant | A/G | snv | 0.30 | 0.25 | 0.010 | 1.000 | 1 | 2017 | 2017 |